The Short Version
Oova and Mira both belong to the quantitative tier: real hormone measurements from urine tests, not threshold smileys. Mira is consumer-first — a standalone analyzer, a wand lineup, and an app built for self-directed TTC tracking of LH, E3G, and PdG. Oova scans its LH + PdG (and in newer kits, estrogen-marker) test strips with your phone camera and was designed from the start around clinician visibility — many users arrive via a fertility practice that monitors their Oova dashboard. Self-directed and want maximum flexibility? Mira. Working with a provider who uses Oova, or wanting your data medically supervised? Oova. Both confirm ovulation via PdG, which is the feature that matters most.
Once you've decided threshold smiley-faces aren't enough — that you want actual hormone values — the shortlist gets small fast. Mira and Inito dominate that conversation, but Oova belongs in it too, and it arrived by a different road: not the consumer gadget aisle, but the fertility clinic. That origin story is the real difference between Oova and Mira, and it's the thing that should drive your choice.
What they share
Both are quantitative urinary hormone monitors. Both track the LH surge with real numbers. Both measure PdG — the progesterone metabolite that rises after ovulation — which means both can confirm ovulation occurred, the defining capability of this tier. Both produce charts a clinician can read at a glance. Whichever you pick, you're getting the fundamental upgrade over ordinary ovulation tests.
Where they diverge
| Oova | Mira | |
|---|---|---|
| Hardware | Phone camera scans test strips | Standalone analyzer reads wands |
| Core markers | LH + PdG (estrogen marker in newer kits) | LH + E3G + PdG (+FSH via Max wand) |
| Built for | Clinician-connected tracking; provider dashboard | Self-directed consumer tracking |
| Confirms ovulation | Yes (PdG) | Yes (PdG) |
| Phone dependency | High — camera does the reading | Low — analyzer reads, then syncs |
| Typical entry point | Often via a fertility practice; also direct | Direct to consumer |
Oova: the clinic-connected strip
Oova's workflow resembles Inito's more than Mira's: dip a strip, scan it with your phone, get quantitative values in the app. What sets Oova apart is upstream — it was built with provider integration at the center. Fertility practices, coaches, and telehealth programs can monitor patients' hormone curves through a dashboard, adjust plans between visits, and catch pattern problems without waiting for the next appointment. If your clinic hands you an Oova kit, that's the ecosystem working as designed.
Mira: the consumer flagship
Mira assumes you're driving. The standalone analyzer reads wands independent of your phone model, the wand lineup covers additional markers (estrogen tracking standard, FSH via Max), and the app is built for self-interpretation with export/sharing when you want a doctor's eyes on it. Full details in our three-way comparison and the Mira vs Inito head-to-head.
Choosing between them
- Your clinic or fertility coach uses Oova: use Oova. Shared dashboards beat forwarded screenshots, and supervised interpretation is the entire point of the platform.
- You're self-directed and want the broadest at-home toolkit: Mira. Standalone hardware, wider wand options, and a mature consumer app.
- You hate phone-camera test workflows: Mira — it's the only analyzer-based option in the quantitative tier.
- You're between doctors but heading toward a workup: either — both produce charts that make a first fertility appointment dramatically more productive.
Which should you choose?
Choose Oova if a provider is (or will be) part of your tracking — its clinician dashboard turns your daily strips into data your care team actually sees, which is a genuinely different product experience than tracking alone.
Choose Mira if you're running your own show and want the most flexible consumer hardware in the quantitative tier — standalone analyzer, expandable wand lineup, no phone-model dependency.
Either way, you get numeric hormone curves and PdG ovulation confirmation — the two capabilities that make this tier worth its price. And if a third name keeps nagging you, the Inito review completes the set.
Frequently asked questions
What's the main difference between Oova and Mira?
Design philosophy. Mira is a consumer device: standalone analyzer, wand ecosystem, self-serve app. Oova is phone-camera-scanned strips with a platform built for clinician oversight — fertility practices can follow patients' hormone data through a provider dashboard. The measurements overlap heavily; the intended relationship with your doctor differs.
Do Oova and Mira both confirm ovulation?
Yes. Both measure PdG (a urinary progesterone metabolite) that rises after ovulation, which is the at-home signal that an egg was actually released. That capability separates both from ordinary LH-only ovulation tests.
Do I need a doctor to use Oova?
No — Oova sells directly to consumers. But its provider-dashboard integration is a signature feature, and if your clinic already works with Oova, using it keeps your care team looking at the same charts you are.
Which costs more, Oova or Mira?
Both follow the consumables model — you'll buy test strips or wands ongoing — and both price kits in the same broad premium range as of this writing. Exact comparisons shift with bundles and subscription options, so price a realistic per-cycle refill cadence on both sites rather than comparing starter kits.
Can either replace lab hormone testing?
No. Urinary hormone monitoring estimates trends; serum labs measure blood concentrations under clinical standards. These devices are superb for cycle patterns and timing, and their charts enrich medical care — they don't replace bloodwork your doctor orders.
Pricing and product details reflect typical 2026 information at the time of writing and change often — always confirm current pricing, subscription terms, and return policies on the manufacturer's site before buying. This article is educational and is not medical advice.